文献速递脑血管病

直接接受血管内治疗患者的介入前再灌注率及质量

Rates and Quality of Preinterventional Reperfusion in Patients With Direct Access to Endovascular Treatment.
PubMed 文献 · Stroke · 2018-01-01

该分析基于前瞻性登记中627例直接入院接受血管造影并拟行血管内治疗的患者,评估介入前再灌注的患病率与质量。介入前闭塞部位改变(COS)总患病率为10.7%,其中TICI≥2a的COS为6.2%,且与静脉tPA治疗相关(aOR 11.98)。TICI≥2a的COS常不完全且51.3%仍需额外血管内治疗,颈内动脉及近端M1闭塞者COS率低且静脉tPA可能与灌注恶化相关。

要点

  • 直接接受血管内治疗患者介入前COS总患病率为10.7%,TICI≥2a的COS为6.2%。
  • 静脉tPA与TICI≥2a的COS相关(aOR 11.98,95%CI 4.5-31.6)。
  • TICI≥2a的COS患者中51.3%仍接受了额外血管内治疗。

核心结论

  • 直接接受血管内治疗的患者中介入前再灌注并不少见,且明显受静脉tPA治疗促进。
  • 介入前再灌注常不完全,且常需额外血管内治疗。
  • 颈内动脉及近端M1闭塞的介入前再灌注罕见且通常质量低,静脉tPA可能促进灌注恶化。

研究设计与样本

  • 前瞻性登记中所有直接入院接受血管造影并拟行血管内治疗的患者(n=627)被回顾分析。

主要发现

  • 所有患者COS患病率为10.7%(95%CI 8.3%-13.1%),其中TICI 0/1的COS为2.7%,TICI≥2a的COS为6.2%(包括TICI≥2b的2.9%),灌注恶化的COS为1.8%。
  • 与TICI≥2a的COS相关的因素包括静脉tPA(aOR 11.98;95%CI 4.5-31.6)、心源性血栓来源(aOR 2.3;95%CI 1.1-4.6)和血栓长度(每增加1 mm的aOR 0.926;95%CI 0.87-0.99)。
  • 尽管TICI≥2a的COS,51.3%的患者仍进行了额外血管内治疗。
  • TICI≥2a的COS显示良好结局(改良Rankin量表≤2)的趋势(aOR 2.65;95%CI 0.98-7.17)。
  • 颈内动脉和近端M1闭塞中TICI≥2a的COS率特别低(2.2%;95%CI 0.9%-5%),其中静脉tPA与灌注恶化相关(aOR 4.33;95%CI 1.12-16.80)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Background and Purpose- Preinterventional reperfusion before endovascular treatment (ET) is a benefit of bridging with intravenous tPA (tissue-type plasminogen activator). However, detailed data on reperfusion quality and rates of obviating ET in a cohort of patients with immediate access to ET is lacking. Purpose of this analysis was to evaluate prevalence and quality of preinterventional reperfusion in mothership patients. Methods- All mothership patients (n=627) from a prospective registry subjected to angiography with an intention to perform ET were reviewed. Preinterventional change of occlusion site (COS) was categorized into COS with Thrombolysis in Cerebral Infarction (TICI) 0/1, COS with TICI ≥2a, COS with TICI ≥2b, and COS with perfusion worsening. Predictors and clinical relevance were evaluated using multivariable logistic regression and results are displayed as adjusted odds ratios (aOR) and corresponding 95% confidence intervals (95% CI). Results- Prevalence of COS in all patients was 10.7% (95% CI, 8.3%-13.1%), subdividing into 2.7% COS with TICI 0/1, 6.2% COS with ≥TICI 2a (including 2.9% with TICI ≥2b), and 1.8% COS with perfusion worsening. Factors related to COS with ≥TICI 2a were intravenous tPA (aOR, 11.98; 95% CI, 4.5-31.6), cardiogenic thrombus origin (aOR, 2.3; 95% CI, 1.1-4.6), and thrombus length (aOR per 1 mm increase 0.926; 95% CI, 0.87-0.99). Additional ET was performed despite COS with ≥TICI 2a in 51.3%. COS with ≥TICI 2a showed a tendency for favorable outcomes (modified Rankin Scale, ≤2; aOR, 2.65; 95% CI, 0.98-7.17). Rates of COS with ≥TICI 2a were particularly low in internal carotid artery and proximal M1 occlusions (2.2%; 95% CI, 0.9%-5%), where intravenous tPA was associated with perfusion worsening (aOR, 4.33; 95% CI, 1.12-16.80). Conclusions- Prevalence of preinterventional reperfusion is non-negligible in patients with direct access to ET and is clearly favored by intravenous tPA treatment. However, it is often incomplete and often requires additional ET. Preinterventional reperfusion of internal carotid artery and proximal M1 occlusions is rare and usually of low quality, where intravenous tPA may also promote perfusion worsening.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Kaesmacher J, Giarrusso M, Zibold F, et al. Rates and Quality of Preinterventional Reperfusion in Patients With Direct Access to Endovascular Treatment. Stroke. 2018. PMID: 29986932. doi:10.1161/STROKEAHA.118.021579

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。